To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Triple reuptake inhibitors
Triple reuptake inhibitors (TRIs) are a relatively new class of antidepressants which are currently undergoing clinical trials for treatment of depression, anxiety disorders and some personality disorders.
Additional recommended knowledge
TRIs target all three of the brain's major neurotransmitters: serotonin, dopamine and noradrenaline.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Triple_reuptake_inhibitors". A list of authors is available in Wikipedia.|